← Back to Search

Other

GL101 for Dry Eye Syndrome

Phase 2
Waitlist Available
Led By Robert Ritch, MD
Research Sponsored by Glia, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 to 4 weeks
Awards & highlights

Study Summary

To evaluate the safety and efficacy of 0.5% GL101 topical gel administered twice daily for 28 days in ameliorating adverse ocular side effects in patients under ongoing treatment with glaucoma medications.

Eligible Conditions
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glaucoma medication ocular side effect symptoms
Secondary outcome measures
Glaucoma medication ocular side effect signs
Other signs
Other outcome measures
Adverse events

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: GL101Active Control1 Intervention
GL101 topical gel
Group II: PlaceboPlacebo Group1 Intervention
Placebo topical gel

Find a Location

Who is running the clinical trial?

Glia, LLCLead Sponsor
4 Previous Clinical Trials
187 Total Patients Enrolled
Robert Ritch, MDPrincipal InvestigatorNew York Eye & Ear Infirmary of Mount Sinai
7 Previous Clinical Trials
534 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101
2016. "Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02656394.
~5 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top